CTCs can be identified by markers like melanoma-associated antigen 3 (MAGE-A3), melanoma cell adhesion molecule (MCAM), melan-A, and chondroitin sulfate proteoglycan (MCSP), which can provide insights into tumor progression and metastatic potential. Here, MCAM is linked to neoplasm.